Design, synthesis, anticancer activity and molecular docking of novel 1H-benzo[d]imidazole derivatives as potential EGFR inhibitors
Cynthia E. Theodore, G. Sivaiah, S. Prasad, K. Yogesh Kumar, M.S. Raghu, Fahd Alharethy, M.K. Prashanth, Byong‐Hun Jeon
Topics & Concepts
ChemistryErlotinibT790MEGFR inhibitorsStereochemistryCombinatorial chemistryDocking (animal)Hep G2ImidazoleDrugEpidermal growth factor receptorPharmacologyIn vitroBiochemistryGefitinibReceptorMedicineNursingLung Cancer Treatments and MutationsCancer therapeutics and mechanismsQuinazolinone synthesis and applications